Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Treasury Shares (2019 - 2021)

Rein Therapeutics (RNTX) has disclosed Treasury Shares for 3 consecutive years, with $250000.0 as the latest value for Q1 2021.

  • Quarterly Treasury Shares rose 400.0% to $250000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $250000.0 through Mar 2021, up 400.0% year-over-year, with the annual reading at $50000.0 for FY2019, N/A changed from the prior year.
  • Treasury Shares for Q1 2021 was $250000.0 at Rein Therapeutics, up from $10000.0 in the prior quarter.
  • The five-year high for Treasury Shares was $250000.0 in Q1 2021, with the low at $10000.0 in Q2 2020.
  • Average Treasury Shares over 3 years is $76666.7, with a median of $50000.0 recorded in 2019.
  • The sharpest move saw Treasury Shares plummeted 80.0% in 2020, then soared 400.0% in 2021.
  • Over 3 years, Treasury Shares stood at $50000.0 in 2019, then tumbled by 80.0% to $10000.0 in 2020, then surged by 2400.0% to $250000.0 in 2021.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $250000.0, $10000.0, and $50000.0 for Q1 2021, Q2 2020, and Q1 2020 respectively.